NIPT is a revolutionary approach to prenatal screening that allows for the detection of genetic conditions in the fetus without invasive procedures like amniocentesis or chorionic villus sampling. The service provided by GGA genetic laboratories utilizes VeriSeq and Verifi Top by Illumina to analyze cell-free DNA in the mother’s blood, providing accurate and reliable results concerning the fetus genetic condition.
Verify detects the following trisomy
VeriSeq
- Down syndrome (trisomy 21) Incidence 1:700
- Edward syndrome (Trisomy 18), Incidence 1:5,000
- Patau syndrome (Trisomy 13), Incidence 1:12,000
- Triple X syndrome (XXX), Incidence 1:1,000
- Klinefelter syndrome (XXY), Incidence 1:1,000
- Terner monosomy (XO), Incidence 1:2,500
- Jacobs syndrome (XYY), Incidence 1:1000
Verifi Top
- Expanded autosomal trisomy in All chromosomes
At our facility, we prioritize providing exceptional service to expecting parents. Our team of experienced professionals ensures that the entire process, from sample collection to result delivery, is seamless and stress-free. We understand the importance of timely and accurate information during pregnancy, and we are committed to delivering results with the highest level of precision and confidentiality
Features:
- Performed as early as 10 weeks gestational age
- A deeper approach to the science of sequencing
- The most accurate answers in NIPT
- Fast turnaround time; results usually available within 5 to 7 business days
- validated on cohort of more than 115,000 clinical samples
